Open original FDA record ↗Recall record
- FDA identifier
- Z-2154-2012
- Company in FDA record
- Greiner Bio-One North America, Inc.
- FDA classification date
- Aug 7, 2012
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 17, 2026
- Recall classification
- Class II
Reason stated in the source
Part of the lot received a lower concentration of citrate solution which may cause falsely lower values for common coagulation tests.
Source facts
- Action
- Distributors were notified by letter on 07/02/2012 and customers were sent a letter dated 07/05/2012. The letters identified the affected product and the reason for the recall. Distributors were asked to stop distributing the affected product and to complete the attached Product Disposition form. The form along with the affected product was to be returned to GBO. The firm will provide replacement stock or issue a credit once product return and receipt of the Product Disposition form has been confirmed. Customers were also asked to complete the Product Disposition Site Confirmation form and fax it back to Greiner Bio-One North America, Inc. at the number provided. The letter states that the firm will replace any affected product once the form is received. Questions should be directed to 800-515-8112.
- Initiated
- 2012-07-02
- Root cause
- Nonconforming Material/Component
- Terminated
- 2013-06-11
- Distribution
- Nationwide Distribution
- Recall number
- Z-2154-2012
- Recall status
- Terminated
- CDRH record ID
- 111118
- FDA classified
- 2012-08-07
- Recall event number
- 62595